[1]
S. M. Naser, “Adverse drug reaction monitoring through active surveillance of antitubercular therapy in an urban tertiary care center: Adverse drug reaction monitoring of antitubercular therapy”, Community Acquir Infect, vol. 3, Jun. 2016.